Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study

The aim of the study was to evaluate the safety and efficacy of a new chemo-radiotherapy regimen for patients with locally advanced pancreatic cancer (LAPC). Patients were treated as follows: gemcitabine 1000 mg/m(2) on day 1, and oxaliplatin 100 mg/m(2) on day 2, every two weeks (GEMOX regimen) for...

Descripción completa

Detalles Bibliográficos
Autores principales: Passardi, Alessandro, Scarpi, Emanuela, Neri, Elisa, Parisi, Elisabetta, Ghigi, Giulia, Ercolani, Giorgio, Gardini, Andrea, La Barba, Giuliano, Pagan, Flavia, Casadei-Gardini, Andrea, Valgiusti, Martina, Ferroni, Fabio, Frassineti, Giovanni Luca, Romeo, Antonino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562444/
https://www.ncbi.nlm.nih.gov/pubmed/31086093
http://dx.doi.org/10.3390/cancers11050663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562444/
https://www.ncbi.nlm.nih.gov/pubmed/31086093
http://dx.doi.org/10.3390/cancers11050663

Ejemplares similares